2023 Kansas Statutes
Chapter 65 - Public Health
Article 41 - Controlled Substances
65-4111 Substances included in schedule IV.

Universal Citation:
KS Stat § 65-4111 (2023)
Learn more This media-neutral citation is based on the American Association of Law Libraries Universal Citation Guide and is not necessarily the official citation.

65-4111. Substances included in schedule IV.
(a) The controlled substances listed in this section are included in schedule IV and the number set forth opposite each drug or substance is the DEA controlled substances code that has been assigned to it.

(b) Any material, compound, mixture or preparation that contains any quantity of the following substances including its salts, isomers and salts of isomers whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation and having a potential for abuse associated with a depressant effect on the central nervous system:

(1)  Alprazolam  2882

(2)  Barbital  2145

(3)  Brexanolone  2400

(4)  Bromazepam   2748

(5)   Camazepam  2749

(6)   Carisoprodol  8192

(7)   Chloral betaine  2460

(8)   Chloral hydrate  2465

(9)   Chlordiazepoxide  2744

(10)   Clobazam  2751

(11)   Clonazepam  2737

(12)   Clorazepate  2768

(13)   Clotiazepam  2752

(14)   Cloxazolam  2753

(15)   Delorazepam  2754

(16)   Diazepam  2765

(17)   Dichloralphenazone  2467

(18)   Estazolam  2756

(19)   Ethchlorvynol  2540

(20)   Ethinamate  2545

(21)   Ethyl loflazepate  2758

(22)   Fludiazepam  2759

(23)   Flunitrazepam  2763

(24)   Flurazepam  2767

(25)   Fospropofol  2138

(26)   Halazepam  2762

(27)   Haloxazolam  2771

(28)   Ketazolam  2772

(29)   Lemborexant  2245

(30)  Loprazolam  2773

(31)   Lorazepam  2885

(32)   Lormetazepam  2774

(33)   Mebutamate  2800

(34)   Medazepam  2836

(35)   Meprobamate  2820

(36)   Methohexital  2264

(37)   Methylphenobarbital (mephobarbital)  2250

(38)   Midazolam  2884

(39)   Nimetazepam  2837

(40)   Nitrazepam  2834

(41)  Nordiazepam  2838

(42)   Oxazepam  2835

(43)   Oxazolam  2839

(44)   Paraldehyde  2585

(45)   Petrichloral  2591

(46)   Phenobarbital  2285

(47)   Pinazepam  2883

(48)   Prazepam  2764

(49)   Quazepam  2881

(50)   Remimazolam  2846

(51)  Temazepam  2925

(52)   Tetrazepam  2886

(53)   Triazolam  2887

(54)   Zolpidem  2783

(55)   Zaleplon  2781

(56)   Zopiclone  2784

(57)  2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol, its salts, opticaland geometric isomers and salts of these isomers (including tramadol).  9752

(58)   Alfaxalone.  2731

(59)   Suvorexant  2223

(c) Any material, compound, mixture, or preparation that contains any quantity of fenfluramine (1670), including its salts, isomers (whether optical, position or geometric) and salts of such isomers, whenever the existence of such salts, isomers and salts of isomers is possible. The provisions of this subsection (c) shall expire on the date fenfluramine and its salts and isomers are removed from schedule IV of the federal controlled substances act (21 U.S.C. § 812; 21 code of federal regulations 1308.14).

(d) Any material, compound, mixture or preparation that contains any quantity of lorcaserin (1625), including its salts, isomers and salts of such isomers, whenever the existence of such salts, isomers and salts of isomers is possible (21 U.S.C. § 812; 21 code of federal regulations 1308.14).

(e) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation that contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers (whether optical, position or geometric) and salts of such isomers whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation:

(1)  Cathine ((+)-norpseudoephedrine)  1230

(2)  Diethylpropion  1610

(3)  Fencamfamin  1760

(4)  Fenproporex  1575

(5)  Mazindol  1605

(6)  Mefenorex  1580

(7)  Pemoline (including organometallic complexes and chelates thereof)  1530

(8)  Phentermine  1640

The provisions of this subsection (e)(8) shall expire on the date phentermine and its salts and isomers are removed from schedule IV of the federal controlled substances act (21 U.S.C. § 812; 21 code of federal regulations 1308.14).

(9)  Pipradrol  1750

(10)  SPA((-)-1-dimethylamino-1, 2-diphenylethane)  1635

(11)  Sibutramine  1675

(12)  Solriamfetol (2-amino-3-phenylpropyl carbamate; benzenepropanol, beta-amino-, carbamate (ester))  1650

(13)  Mondafinil  1680

(f) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation that contains any quantity of the following, including salts thereof:

(1)  Pentazocine  9709

(2)  Butorphanol (including its optical isomers)  9720

(3)  Eluxadoline (5-[[[(2S)-2-amino-3-[4-aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl][(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]amino]methyl]-2-methoxybenzoic acid) (including its optical isomers) and its salts, isomers, and salts of isomers  9725

(g) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below:

(1)  Not more than 1 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit  9167

(2)  Dextropropoxyphene (alpha-(+)-4-dimethylamino-1, 2-diphenyl-3-methyl-2-propion-oxybutane)  9278

(h) Butyl nitrite and its salts, isomers, esters, ethers or their salts.

(i) The board may except by rule and regulation any compound, mixture or preparation containing any depressant substance listed in subsection (b) from the application of all or any part of this act if the compound, mixture or preparation contains one or more active medicinal ingredients not having a depressant effect on the central nervous system, and if the admixtures are included therein in combinations, quantity, proportion or concentration that vitiate the potential for abuse of the substances that have a depressant effect on the central nervous system.

History: L. 1972, ch. 234, § 11; L. 1974, ch. 258, § 5; L. 1978, ch. 257, § 3; L. 1979, ch. 204, § 1; L. 1982, ch. 269, § 5; L. 1985, ch. 220, § 4; L. 1986, ch. 241, § 3; L. 1989, ch. 200, § 4; L. 1990, ch. 231, § 1; L. 1991, ch. 199, § 4; L. 1993, ch. 70, § 2; L. 1996, ch. 257, § 2; L. 1998, ch. 190, § 1; L. 2000, ch. 108, § 4; L. 2001, ch. 171, § 5; L. 2011, ch. 83, § 6; L. 2012, ch. 107, § 8; L. 2014, ch. 79, § 3; L. 2015, ch. 27, § 4; L. 2016, ch. 95, § 4; L. 2017, ch. 57, § 6; L. 2022, ch. 99, § 5; June 9.

Disclaimer: These codes may not be the most recent version. Kansas may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.